U.S. Healthcare Services Stock News

Earlier this week, Viavi Solutions Inc. was awarded €1.1 million in funding from the European Smart Networks and Services Joint Undertaking and Horizon Europe to support the SHIELD-6G project, which will use the company’s TeraVM AI RAN Scenario Generator to create digital twins for AI-driven 6G security testing and compliance. The funding places Viavi inside a high-profile European 6G consortium alongside Ericsson, Nokia, THALES, Telefónica and others, potentially reinforcing its role in...

In recent trading, United Bankshares moved in step with a broader rally in regional bank stocks after softer-than-expected US inflation data reduced fears of additional Federal Reserve rate hikes. This macro backdrop, combined with strong second-quarter earnings from major financial institutions, improved sentiment toward smaller lenders such as United Bankshares by highlighting more stable net interest income and easing deposit costs. We will now examine how easing rate-hike concerns,...

ProPetro Holding (PUMP) is back on investors’ radar after recent trading showed mixed momentum, with the stock down 5.1% on the day and about 14% over the past month. See our latest analysis for ProPetro Holding. While ProPetro Holding’s 1 day share price return declined 5.14% and its 30 day share price return is down 14.21%, the 1 year total shareholder return of 120.03% and 5 year total shareholder return of 58.06% suggest longer term momentum has been stronger than the recent pullback. If...

Alkermes (ALKS) recently reported interim data from its long term extension study of alixorexton in narcolepsy and idiopathic hypersomnia, highlighting sustained treatment effects through 24 weeks and a generally favorable safety and tolerability profile. See our latest analysis for Alkermes. The latest alixorexton data lands after a strong run in Alkermes stock, with a 30 day share price return of 17.8% and a 90 day share price return of 50.42%. This has contributed to an 83.79% year to date...

Recent commentary on Byline Bancorp highlights that its revenue growth and net interest income have lagged banking peers, with incremental sales proving less profitable as earnings per share trailed revenue gains. This weaker profitability profile, alongside a modest forward price-to-book ratio that reflects market caution over earnings potential, raises questions about how effectively Byline can convert future growth into returns for investors. We’ll now examine how concerns over slower...

Fifth Third Bancorp (FITB) is drawing fresh attention after Fifth Third Bank was named Best Treasury and Cash Management Bank in the United States for a third straight year, alongside the introduction of new AI powered and digital tools for business clients. See our latest analysis for Fifth Third Bancorp. Those treasury awards and new AI powered tools arrive at a time when Fifth Third Bancorp’s momentum is already strong, with the share price at $59.37 and a 30 day share price return of...

Archrock (AROC) has set August 5, 2026, as the date for its second quarter 2026 earnings call. Financial and operating results are due out shortly before the scheduled webcast and phone conference. See our latest analysis for Archrock. Archrock’s share price has eased in the short term, with a 1-day share price return of 1.49% lower and a 7-day share price return of 4.10% lower. However, the year-to-date share price return of 38.68% and 1-year total shareholder return of 63.73% indicate...

In July 2026, Shopify Inc. announced that DoorDash Inc. is now available as a native sales channel in Shopify’s App Store for US brick-and-mortar merchants, while Hungry Howie’s Enterprises, LLC unveiled a phased collaboration with DoorDash Inc. to rebuild its digital ordering, loyalty, and delivery fulfillment platforms through DoorDash’s Commerce Platform. Together with DoorDash’s new dd-cli AI ordering interface and ongoing work in autonomous delivery, these partnerships show DoorDash...

CSW Industrials (CSW) stock drew fresh attention after recent price moves, with the shares last closing at $300.67. Investors are weighing this level against the company’s fundamentals and multi-year return profile. See our latest analysis for CSW Industrials. The recent 2.23% 1 day share price return at $300.67 caps a strong 7 day share price return of 10.50%, while the 1 year total shareholder return of 3.64% sits against a much stronger 3 year total shareholder return of 75.53%. This hints...

Pentair (PNR) is under pressure after a sharp earnings warning tied to its Pool segment, a cut to second quarter and full year 2026 guidance, and the abrupt departure of its recently appointed CFO. See our latest analysis for Pentair. The sharp guidance cut and CFO change have come on top of an already weak run for Pentair, with the share price down 37.7% year to date and the 1 year total shareholder return also declining 37.8%. However, the 3 and 5 year total shareholder returns are slightly...

In recent months, VICI Properties has been the focus of new and reaffirmed analyst coverage while also announcing, alongside Club Med, the acquisition and planned redevelopment of the Carambola Beach Resort in the U.S. Virgin Islands. This mix of analyst caution around tenant risks and rent terms, set against expansion into resort redevelopment, frames a complex outlook for VICI’s income stability and growth ambitions. Next, we’ll examine how concerns about potential rent cuts on key Caesars...

Starwood Property Trust (STWD) is back in focus after its board declared a second quarter dividend of $0.48 per share, extending a payout level that has been unchanged for more than ten years. See our latest analysis for Starwood Property Trust. At a share price of $17.09, Starwood Property Trust has seen a 1-day share price return of 2.58% and a 7-day share price return of 3.89%. The 90-day share price return is down 5.79% and the year-to-date share price return is down 7.22%, while the...

Medtronic (NYSE:MDT) has completed its acquisition of SPR Therapeutics. The deal adds SPR Therapeutics' minimally invasive, non opioid SPRINT PNS pain therapy system to Medtronic's portfolio. The transaction expands Medtronic's presence in the pain management market and broadens treatment options for patients and physicians. Medtronic operates across multiple medical technology segments, and pain management is one of its key therapy areas. By bringing SPRINT PNS into its offering, Medtronic...

CBRE Group’s latest moves in multifamily finance CBRE Group (CBRE) is in focus after hiring Robert Koontz as Senior Managing Director, Head of Multifamily Debt Capital Markets, and helping Venu Holding Corporation line up more than $150 million in C PACE financing. See our latest analysis for CBRE Group. At a share price of $143.69, CBRE Group has seen short term momentum pick up, with a 1 month share price return of 6.07%. However, the share price is down 10.30% year to date, and longer term...

Recently, coverage of ESCO Technologies highlighted its positive earnings surprise history and current Earnings ESP of 1.06%, alongside a Zacks Rank of 2 (Buy), pointing to improving analyst expectations ahead of its next quarterly report. This shift in sentiment suggests analysts are assigning greater importance to ESCO’s ability to outperform consensus forecasts, which can influence how investors interpret the company’s earnings quality and consistency. We’ll now examine how this renewed...

Earlier this week, Merck & Co. received U.S. FDA approval for LIPFENDRA (enlicitide), the first once-daily oral PCSK9 inhibitor, after Phase 3 trials showed substantial LDL cholesterol reductions in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia. This first-in-class oral PCSK9 pill could reshape cholesterol management by offering an easier alternative to injectables for a very large patient population. Now we’ll examine how launching the first oral...

Upcoming earnings date puts Middlesex Water stock in focus Middlesex Water (MSEX) is set to report its second quarter 2026 results after the market closes on Thursday, July 30, an event that can reshape how investors think about the utility’s recent share performance. See our latest analysis for Middlesex Water. Recent trading has been supportive for Middlesex Water, with a 1 month share price return of 8.57% and a 3 month share price return of 11.05%. However, the 5 year total shareholder...

Options activity puts First Financial Bancorp (FFBC) in focus Unusual options activity has put First Financial Bancorp (FFBC) in the spotlight, with the August 21, 2026 $40 call ranking among the highest implied volatility equity contracts in recent trading. The elevated implied volatility indicates that options traders are positioning for a sizable move in First Financial Bancorp, whether higher or lower. It also gives stock investors another data point to consider alongside...

In recent months, First Solar has faced multiple securities class action lawsuits alleging misleading statements about its handling of U.S. tariff impacts and production underutilization, following weaker-than-expected results and reduced guidance for fiscal 2026. These legal challenges put a spotlight on how closely First Solar’s policy-sensitive business model and operational choices are being watched by investors and regulators. We’ll now examine how the surge in tariff‑related...

West Pharmaceutical Services has delivered a 64.1% return over the past year, and after that kind of run the stock no longer looks obviously cheap, especially with most of the valuation checks leaning toward a premium price tag. The Discounted Cash Flow (DCF) intrinsic value estimate points to a roughly fair valuation, while market based multiples suggest the shares are priced on the rich side. West Pharmaceutical Services' 64.1% 1 year return puts recent momentum front and center, which can...

Stoke Therapeutics recently appointed Thomas McCauley, Ph.D., as Chief Scientific Officer, bringing more than 25 years of R&D leadership experience across genetic medicines and rare diseases, and granted him stock options under its 2023 Inducement Plan. McCauley’s background in building and advancing RNA and genetic medicine platforms may be especially relevant as Stoke seeks to progress its antisense oligonucleotide pipeline in severe genetic disorders. Next, we’ll examine how adding an...

Acquisition of Eagle Wing Tours draws fresh attention to Pursuit Attractions and Hospitality Pursuit Attractions and Hospitality (PRSU) has drawn fresh investor attention after acquiring Eagle Wing Tours in Victoria, British Columbia. The transaction adds a marine wildlife experience and provides entry into the Vancouver Island tourism market. See our latest analysis for Pursuit Attractions and Hospitality. For context, Pursuit Attractions and Hospitality’s recent acquisition headlines come...

Prologis (PLD) raised its 2026 net earnings guidance to a range of $4.40 to $4.55 per diluted share, up from $3.80 to $4.05, following record leasing and firmer operating fundamentals. See our latest analysis for Prologis. The guidance upgrade came alongside a sharp 1 day share price return of 4.63%, contributing to a 16.28% year to date share price return. The 1 year total shareholder return of 45.56% points to momentum that has been building over a longer period. If Prologis has you...

Rambus (RMBS) recently introduced its DDR5 9600 Server RDIMM chipset, a high speed memory solution aimed at next generation data center platforms handling agentic AI, high performance computing, and other intensive workloads. See our latest analysis for Rambus. Despite the new DDR5 9600 Server RDIMM chipset announcement, Rambus shares have pulled back recently, with the 30 day share price return down 23.45% and the 90 day share price return down 20.10%. The 1 year total shareholder return...